VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FBRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
FBRXForte Biosciences, Inc.
$22.25$4.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksFBRXQuarterly Financials

Forte Biosciences, Inc. (FBRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Forte Biosciences, Inc. (FBRX) quarterly income statement — complete revenue, gross profit & net income history

FBRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold19K-45K17K15K13K10K10K10K9K6K3K00000009K13K
COGS % of Revenue--------------------
Gross Profit-19K45K-17K-15K-13K-10K-10K-10K-9K-6K-3K0000000-9K-13K
Gross Margin %--------------------
Gross Profit Growth %-46.15%550%-70%-50%-44.44%-66.67%-233.33%-------100%100%100%---
Operating Expenses22.44M24.62M18.37M11.56M16.11M7.34M8.62M12.81M7.79M6.38M10.21M9.03M6.86M4.94M3.42M3.02M2.51M3.3M7.69M5.75M
OpEx % of Revenue--------------------
Selling, General & Admin1.97M2.83M3.18M2.96M3.43M2.11M2.76M7.08M3.44M2.81M3.85M1.9M2.07M2.45M2.04M1.99M1.82M1.95M2.04M2.22M
SG&A % of Revenue--------------------
Research & Development20.32M21.44M15.05M8.62M12.54M5.23M5.72M5.74M4.35M3.57M6.37M7.14M4.79M2.49M1.38M1.03M693K1.35M5.65M3.52M
R&D % of Revenue--------------------
Other Operating Expenses150K345K150K0150K0150K00000000-15K0000
Operating Income-22.44M-24.57M-18.38M-11.58M-16.12M-7.35M-8.63M-12.82M-7.8M-6.38M-10.22M-9.03M-6.86M-4.94M-3.42M-3.02M-2.51M-3.3M-7.7M-5.75M
Operating Margin %--------------------
Operating Income Growth %-39.17%-234.25%-113.04%9.67%-106.61%-15.2%15.53%-41.89%-13.84%-29.2%-198.45%-199.14%-172.67%-49.71%55.54%47.45%46.97%26.57%-53.73%83.46%
EBITDA-22.42M-24.55M-18.37M-11.56M-16.11M-7.34M-8.62M-12.81M-7.79M-6.38M-10.21M0-6.75M-4.93M-3.4M-3.01M-2.57M-3.34M-7.69M-5.73M
EBITDA Margin %--------------------
EBITDA Growth %-39.16%-234.45%-113.09%9.71%-106.68%-15.15%15.61%--15.43%-29.31%-200.38%100%-163.07%-47.56%55.79%47.49%45.69%25.41%-53.95%83.49%
D&A (Non-Cash Add-back)19K19K17K15K13K10K10K10K9K6K3K9.03M09K09K009K13K
EBIT-22.44M-24.57M-17.68M-11.58M-16.12M-7.16M-8.63M-12.82M-7.8M-7M-10.22M-9.03M-6.75M-4.94M-3.4M-3.02M-2.57M-3.34M-7.75M-5.75M
Net Interest Income000001.31M0001.02M000-6K0-15K-53K-42K00
Interest Income000001.31M0001.12M0000000000
Interest Expense000000000102K0006K015K53K42K00
Other Income/Expense676K820K701K330K468K196K237K307K384K509K261K138K102K62K23K-15K-53K-42K-52K-65K
Pretax Income-21.76M-23.75M-17.68M-11.25M-15.66M-7.16M-8.39M-12.51M-7.42M-5.87M-9.96M-8.9M-6.75M-4.88M-3.4M-3.04M-2.57M-3.34M-7.75M-5.81M
Pretax Margin %--------------------
Income Tax373K1.04M000000000000000000
Effective Tax Rate %-1.71%-4.37%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-22.14M-24.79M-17.68M-11.25M-15.66M-7.16M-8.39M-12.51M-7.42M-5.87M-9.96M-8.9M-6.75M-4.88M-3.4M-3.05M-2.57M-3.34M-7.75M-5.81M
Net Margin %--------------------
Net Income Growth %-41.39%-246.44%-110.7%10.09%-111%-21.85%15.7%-40.64%-9.88%-20.25%-192.79%-191.67%-163.07%-46.15%56.13%47.52%46.57%26.99%-51.98%83.28%
Net Income (Continuing)-22.14M-24.79M-17.68M-11.25M-15.66M-7.16M-8.39M-12.51M-7.42M-5.87M-9.96M-8.9M-6.75M-4.88M-3.4M-3.04M-2.57M-3.34M-7.75M-5.81M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.24-1.39-0.99-0.96-1.37-1.12-4.54-6.78-4.77-4.04-6.57-10.57-8.04-5.81-4.49-5.14-4.35-5.66-13.61-10.68
EPS Growth %9.49%-24.11%78.19%85.84%71.28%72.28%30.93%35.84%40.65%30.41%-46.37%-105.58%-84.84%-2.56%67%51.88%52.02%36.51%41.25%95.51%
EPS (Basic)-1.24-1.39-0.99-0.96-1.37-1.12-4.54-6.78-4.77-4.04-6.57-10.57-8.04-5.81-4.49-5.14-4.35-5.66-13.61-10.68
Diluted Shares Outstanding178.37M147.18M17.79M11.74M11.4M6.39M1.85M1.85M1.55M1.45M1.51M841.87K840.27K840K757.1K590.45K590.39K590.18K569.65K544.13K
Basic Shares Outstanding178.37M147.18M17.79M11.74M11.4M6.39M1.85M1.85M1.55M1.45M1.51M841.87K840.27K840K757.1K590.45K590.39K590.18K569.65K544.13K
Dividend Payout Ratio--------------------